|
|
Article: Galileo Genomics Announces An Additional CAD $7 Million Financing Trough An Investissement Quebec Loan.
- Article from:
- PR Newswire
- Article date:
- January 19, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, Jan. 19 /PRNewswire/ -- Galileo Genomics Inc., a Montreal-based next generation genomics company, today announced that Investissement Quebec, is providing a CAD$7 million loan under its BioLevier program. Galileo will use these additional funds to accelerate the search for genes associated with more than 20 common and economically important diseases. Galileo had previously announced on January 7, 2004 an equity financing of $11.15 million.
The objective is the discovery of "GeneMaps", groups of common interacting genes that are directly and unequivocally involved in disease- causing biochemical processes. These are expected to lead to new drug and ...